Physician profile
Joseph B Carlock
NPI 1881822674
$419.81
in general payments reported to CMS, 2019-2025
8 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Spinal Cord Injury Medicine provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2023: $33.44 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $123.61 | 2019 | |
| Saluda Medical Americas, INC. | $121.32 | 2025 | Evoke |
| Medtronic, INC. | $56.11 | 2025 | Synchromedii, Intellis Adaptivestim |
| Ipsen Biopharmaceuticals, INC | $33.44 | 2023 | Dysport |
| Curonix LLC | $29.50 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.75 | 2025 | Relistor |
| Globus Medical, INC. | $18.35 | 2025 | Omnia |
| Valinor Pharma, LLC | $16.73 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Carlock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.